Ustekinumab Completed Phase N/A Trials for Moderate to Severe Palmar Plantar Psoriasis Treatment

IndicationsStatusPurposePhase
CompletedTreatmentNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT01090063Efficacy and Safety of Ustekinumab in Patients With Moderate to Severe Palmar Plantar Psoriasis